Pilot Study on Quantitative Cervical Cord and Muscular MRI in Spinal Muscular Atrophy: Promising Biomarkers of Disease Evolution and Treatment?

Introduction: Nusinersen is a recent promising therapy approved for the treatment of spinal muscular atrophy (SMA), a rare disease characterized by the degeneration of alpha motor neurons (αMN) in the spinal cord (SC) leading to progressive muscle atrophy and dysfunction. Muscle and cervical SC quan...

Descripción completa

Detalles Bibliográficos
Autores principales: Savini, Giovanni, Asteggiano, Carlo, Paoletti, Matteo, Parravicini, Stefano, Pezzotti, Elena, Solazzo, Francesca, Muzic, Shaun I., Santini, Francesco, Deligianni, Xeni, Gardani, Alice, Germani, Giancarlo, Farina, Lisa M., Bergsland, Niels, Gandini Wheeler-Kingshott, Claudia A. M., Berardinelli, Angela, Bastianello, Stefano, Pichiecchio, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039452/
https://www.ncbi.nlm.nih.gov/pubmed/33854470
http://dx.doi.org/10.3389/fneur.2021.613834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039452/
https://www.ncbi.nlm.nih.gov/pubmed/33854470
http://dx.doi.org/10.3389/fneur.2021.613834

Ejemplares similares